Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy
Nemoto, Kenji, Shibamoto, Yuta, Ohmagari, Jun-ichi, Baba, Yuji, Ebe, Kazuyu, Ariga, Hisanori, Takai, Yoshihiro, Ouchi, Atsushi, Sasai, Keisuke, Shinozaki, Misao, Tsujitani, Michihiko, Sakaguchi, MasakVolume:
12
Language:
english
Journal:
Anti-Cancer Drugs
DOI:
10.1097/00001813-200101000-00001
Date:
January, 2001
File:
PDF, 102 KB
english, 2001